Romano Brothers & Co’s Hologic HOLX Stock Holding History

Romano Brothers & Co’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-333	Closed	-$24.9K	–	574
2022 Q4	$24.9K	Buy	+333	New	+$23.7K	﹤0.01%	584

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Romano Brothers & Co's HOLX Position: Q1 2023 in Review

Romano Brothers & Co sold out of Hologic (HOLX) in Q1 2023, closing a stake of 333 shares — an estimated $24.9K sold.

Romano Brothers & Co first reported a position in HOLX in Q4 2022 and held it in 1 quarter. The position peaked at $24.9K in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

Romano Brothers & Co reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 333 Hologic shares in Q1 2023, an estimated $24.9K.
Romano Brothers & Co first reported a position in Hologic in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Hologic position peaked at $24.9K in Q4 2022.
708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.